SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (1373)8/3/2002 3:05:55 PM
From: smh  Respond to of 1475
 
TD

Elliot always spoke about 507 with confident enthusiasm. I heard no enthusiasm on this call. And what ever happened to the IND for RA?

SMH



To: Arthur Radley who wrote (1373)8/24/2002 9:49:42 PM
From: Arthur Radley  Respond to of 1475
 
MEDI has until August 31st to file a proposal to present data at the upcoming European Dermatology meeting in October. The Phase II trials were concluded sometime ago, and IMO MEDI has had sufficient time to review the data collected, therefore, it is time to come clean with investors...and this conference is the time and place to put up or shut up! Either I see a proposal being submitted or I'm out of here.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News